Please login to the form below

Not currently logged in
Email:
Password:

Adventis buys Roundhouse

Multimedia agency swoops to boost its healthcare sector offering

Roundhouse HealthAd has been snapped up by specialist multimedia and marketing agency, the Adventis Group.

Adventis, which bought Chesham-based healthcare media agency, Affiniti, in December 2004, is looking to boost its healthcare offering with the purchase.

ìI am confident that we have laid the foundation for a significant player within the healthcare industry,î said Charles Phillpot, chairman of Adventis. ìWe do not wish to lose what Roundhouse has already built themselves upon, but to develop the model further. We are confident having Roundhouse and Affiniti in the group will generate a large and vibrant healthcare business that can exploit its premier market position.î

Roundhouse managing director, Kevin McGetrick said that when his firm was first approached by Adventis, ìwe were amazed by the sense of shared vision and felt they could become an ideal partner to move the business forwardî.

ìIt was equally important to find that Affiniti had a portfolio of clients and skills that were complementary to our own and there will be synergies almost immediately,î he commented.

Adventis will pay £1.6m for Roundhouse, making an additional cash payment in respect of its net assets, estimated at £400,000, at completion.

Adventis said further announcements, which will most likely concern the launch of a full-service offering including medical education, would be made later this year.

Roundhouse has been trading for over 10 years and has 12 staff, who will continue to operate from its current headquarters near Hertford. The agency's pharma clients include Baxter, Boehringer Ingelheim, Merial, Organon, Pfizer AH and Schering-Plough.

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics